Skip to content

Clinical study on the treatment of diabetic peripheral neuropathy with "Tongluobuxu" electroacupuncture

Clinical study on the treatment of diabetic peripheral neuropathy with "Tongluobuxu" electroacupuncture

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400086010
Enrollment
Unknown
Registered
2024-06-24
Start date
2024-07-01
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic peripheral neuropathy

Interventions

Control group:On the basis of routine hypoglycemic treatment, methamphetamine tablets 0.5mg, 3 times/day orally. Follow a course of 7 days, take 4 consecutive courses. The specification of methyldiami
Treatment group:On the basis of the treatment of the control group, the "Tongluo tonifying deficiency" electroacupuncture treatment was given, 30min/ time /d, 6 times for 1 course of treatment and 1 d

Sponsors

The First Affiliated Hospital of Henan University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 70 Years

Inclusion criteria

Inclusion criteria: ? It meets the clinical diagnostic criteria of DPN in this study and TCM syndrome differentiation is Yin deficiency and blood stasis type; ? Age 35-70 years old; ? Vital signs were stable, blood pressure, heart rate and other indicators were normal; ? Normal cognitive ability and expression ability, no serious cardiovascular and cerebrovascular diseases; ? No other peripheral nervous system lesions; ? Volunteer to participate in this study and sign informed consent, can cooperate with doctors to complete clinical research.

Exclusion criteria

Exclusion criteria: ? Patients who are sensitive to acupuncture and moxibustion appear dizzy; ? Under the age of 35 or over the age of 70; ? Intending to rape women or women in pregnancy, breastfeeding women, and long-term use of contraceptives; ? Severe complications of diabetes, or combined with hyperthyroidism and other diseases affecting blood sugar; ? Patients with neuropathy caused by other factors or complicated with intervertebral disc disease, spinal radiculopathy, etc.; ? Patients with serious primary diseases or serious diseases such as malignant tumors, serious genetic diseases or infectious diseases; ? Those who have received other or similar clinical trials within the last 3 months; ? Bleeding tendency or occurrence of bleeding within the past 1 month; ? Have a history of alcoholism or drug abuse; ? There are skin diseases or infected people at the acupuncture site.

Design outcomes

Primary

MeasureTime frame
TCM syndrome integral;TCSS nervous system integral;

Secondary

MeasureTime frame
Current Sensing Value Measurement (CPT);

Countries

China

Contacts

Public ContactCao Fang

The First Affiliated Hospital of Henan University of Chinese Medicine

caofang2008@126.com+86 150 9316 6130

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026